Literature DB >> 18234796

Adenovirus E1B55K region is required to enhance cyclin E expression for efficient viral DNA replication.

Xinyu Zheng1, Xiao-Mei Rao, Jorge G Gomez-Gutierrez, Hongying Hao, Kelly M McMasters, H Sam Zhou.   

Abstract

Adenoviruses (Ads) with E1B55K mutations can selectively replicate in and destroy cancer cells. However, the mechanism of Ad-selective replication in tumor cells is not well characterized. We have shown previously that expression of several cell cycle-regulating genes is markedly affected by the Ad E1b gene in WI-38 human lung fibroblast cells (X. Rao, et al., Virology 350:418-428, 2006). In the current study, we show that the Ad E1B55K region is required to enhance cyclin E expression and that the failure to induce cyclin E overexpression due to E1B55K mutations prevents viral DNA from undergoing efficient replication in WI-38 cells, especially when the cells are arrested in the G(0) phase of the cell cycle by serum starvation. In contrast, cyclin E induction is less dependent on the function encoded in the E1B55K region in A549 and other cancer cells that are permissive for replication of E1B55K-mutated viruses, whether the cells are in the S phase or G(0) phase. The small interfering RNA that specifically inhibits cyclin E expression partially decreased viral replication. Our study provides evidence suggesting that E1B55K may be involved in cell cycle regulation that is important for efficient viral DNA replication and that cyclin E overexpression in cancer cells may be associated with the oncolytic replication of E1B55K-mutated viruses.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18234796      PMCID: PMC2268468          DOI: 10.1128/JVI.01708-07

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  96 in total

Review 1.  Replication-selective virotherapy for cancer: Biological principles, risk management and future directions.

Authors:  D Kirn; R L Martuza; J Zwiebel
Journal:  Nat Med       Date:  2001-07       Impact factor: 53.440

2.  A new vector system with inducible E2a cell line for production of higher titer and safer adenoviral vectors.

Authors:  H Zhou; A L Beaudet
Journal:  Virology       Date:  2000-09-30       Impact factor: 3.616

3.  Sensitive assay of RNA interference in Drosophila and Chinese hamster cultured cells using firefly luciferase gene as target.

Authors:  K Ui-Tei; S Zenno; Y Miyata; K Saigo
Journal:  FEBS Lett       Date:  2000-08-18       Impact factor: 4.124

4.  Adenovirus E1B 55-kilodalton protein is required for both regulation of mRNA export and efficient entry into the late phase of infection in normal human fibroblasts.

Authors:  Ramon Gonzalez; Wenying Huang; Renee Finnen; Courtney Bragg; S J Flint
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

5.  The adenovirus E4orf6 protein can promote E1A/E1B-induced focus formation by interfering with p53 tumor suppressor function.

Authors:  M Nevels; S Rubenwolf; T Spruss; H Wolf; T Dobner
Journal:  Proc Natl Acad Sci U S A       Date:  1997-02-18       Impact factor: 11.205

6.  Adenovirus E1A proteins can dissociate heteromeric complexes involving the E2F transcription factor: a novel mechanism for E1A trans-activation.

Authors:  S Bagchi; P Raychaudhuri; J R Nevins
Journal:  Cell       Date:  1990-08-24       Impact factor: 41.582

7.  Adenovirus type 5 E1A gene therapy for ovarian clear cell carcinoma: a potential treatment strategy.

Authors:  Hiroaki Itamochi; Junzo Kigawa; Yasunobu Kanamori; Tetsuro Oishi; Chandra Bartholomeusz; Rita Nahta; Francisco J Esteva; Nour Sneige; Naoki Terakawa; Naoto T Ueno
Journal:  Mol Cancer Ther       Date:  2007-01-11       Impact factor: 6.261

8.  Regulation of retinoblastoma protein functions by ectopic expression of human cyclins.

Authors:  P W Hinds; S Mittnacht; V Dulic; A Arnold; S I Reed; R A Weinberg
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

9.  Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein.

Authors:  P R Yew; A J Berk
Journal:  Nature       Date:  1992-05-07       Impact factor: 49.962

10.  Adenovirus with insertion-mutated E1A selectively propagates in liver cancer cells and destroys tumors in vivo.

Authors:  Tiejun Zhao; Xiao-Mei Rao; Xiaoming Xie; Ling Li; Timothy C Thompson; Kelly M McMasters; Heshan Sam Zhou
Journal:  Cancer Res       Date:  2003-06-15       Impact factor: 12.701

View more
  29 in total

Review 1.  Adenovirus E1B 55-kilodalton protein: multiple roles in viral infection and cell transformation.

Authors:  Andrew N Blackford; Roger J A Grand
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

2.  The adenoviral E1B 55-kilodalton protein controls expression of immune response genes but not p53-dependent transcription.

Authors:  Daniel L Miller; Brenden Rickards; Michael Mashiba; Wenying Huang; S J Flint
Journal:  J Virol       Date:  2009-02-11       Impact factor: 5.103

3.  Downregulation of Mdm2 and Mdm4 enhances viral gene expression during adenovirus infection.

Authors:  Heng Yang; Zhi Zheng; Lisa Y Zhao; Qiang Li; Daiqing Liao
Journal:  Cell Cycle       Date:  2012-02-01       Impact factor: 4.534

4.  The role of JNK phosphorylation as a molecular target to enhance adenovirus replication, oncolysis and cancer therapeutic efficacy.

Authors:  Stephen L Wechman; Xiao-Mei Rao; Jorge G Gomez-Gutierrez; Heshan Sam Zhou; Kelly M McMasters
Journal:  Cancer Biol Ther       Date:  2018-08-01       Impact factor: 4.742

5.  Enhanced cancer cell killing by truncated E2F-1 used in combination with oncolytic adenovirus.

Authors:  Jorge G Gomez-Gutierrez; Xiao-Mei Rao; Heshan Sam Zhou; Kelly M McMasters
Journal:  Virology       Date:  2012-09-27       Impact factor: 3.616

6.  Homologous recombination-based adenovirus vector system for tumor cell-specific gene delivery.

Authors:  Qin Lu; Xun Ye; Fang Liu; Yi Zhao; Jie Qin; Min Liang; Chao Fang; Hong-Zhuan Chen
Journal:  Cancer Biol Ther       Date:  2013-06-12       Impact factor: 4.742

7.  Developing adenoviral vectors encoding therapeutic genes toxic to host cells: comparing binary and single-inducible vectors expressing truncated E2F-1.

Authors:  Jorge G Gomez-Gutierrez; Xiao-Mei Rao; Aracely Garcia-Garcia; Hongying Hao; Kelly M McMasters; H Sam Zhou
Journal:  Virology       Date:  2009-12-08       Impact factor: 3.616

8.  Oncolytic Viruses for Cancer Therapy: Overcoming the Obstacles.

Authors:  Han Hsi Wong; Nicholas R Lemoine; Yaohe Wang
Journal:  Viruses       Date:  2010-01       Impact factor: 5.818

9.  A dynamical systems model for combinatorial cancer therapy enhances oncolytic adenovirus efficacy by MEK-inhibition.

Authors:  Neda Bagheri; Marisa Shiina; Douglas A Lauffenburger; W Michael Korn
Journal:  PLoS Comput Biol       Date:  2011-02-17       Impact factor: 4.475

10.  p53-dependent antiviral RNA-interference facilitates tumor-selective viral replication.

Authors:  Engin Gürlevik; Norman Woller; Peter Schache; Nisar P Malek; Thomas C Wirth; Lars Zender; Michael P Manns; Stefan Kubicka; Florian Kühnel
Journal:  Nucleic Acids Res       Date:  2009-05-14       Impact factor: 16.971

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.